PI-RADS: multiparametric MRI in prostate cancer

This article was originally published here

MAGMA. 2022 May 21. doi: 10.1007/s10334-022-01019-1. Online ahead of print.


Multiparametric MRI of the prostate gland has become the initial evaluation of biopsy naïve men with a clinical suspicion for prostate cancer. PI-RADS 2.1 is a joint initiative and framework for prostate MRI acquisition and reporting, which aims to standardize technique and interpretation across centers. Building upon experience accrued following the introduction of PI-RADS 2.0, version 2.1 provides key updates and important clarifications, although it is intended to be an active document, which continues to be updated. Continued advances in our understanding of prostate cancer and progress in imaging technology will undoubtedly shape future iterations of the reporting system.

PMID:35596009 | DOI:10.1007/s10334-022-01019-1